ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has authorised Vocabria (cabotegravir ...
Opinion - While aid has saved lives--providing antiretroviral therapy for 1.4 million Ugandans living with HIV, supporting maternal health programmes, and funding electricity connections in ...